Simultaneous depletion of neurokinin A, substance P and calcitonin gene-related peptide from the caudal trigeminal nucleus of the rat during electrical stimulation of the trigeminal ganglion

Pain

Volumn 84, Issue 2-3, 2000, Pages 389-395

  Samsam, M ^a,b   Covenas R ^a   Ahangari, R ^a,b   Yajeya, J ^c   Narvaez J A ^d   Tramu, G ^e  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b Lab Neuroanatomia Los Sist P   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

^d UNIVERSITY OF MÁLAGA   (Spain)

^e UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Calcitonin gene related peptide; Caudal trigeminal nucleus; Co release; Migraine; Neurokinin A; Substance P

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROKININ A; NEUROPEPTIDE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPLETION; ELECTRODE; ELECTROSTIMULATION; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MIGRAINE; NEUROGENIC INFLAMMATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; STEREOTAXIC SURGERY; TRIGEMINAL NUCLEUS; TRIGEMINUS GANGLION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; ELECTRIC STIMULATION; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NEUROKININ A; RATS; RATS, WISTAR; SUBSTANCE P; TRIGEMINAL GANGLION; TRIGEMINAL NUCLEUS, SPINAL;

EID: 0343820002     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00240-7     Document Type: Article

References (48)

1. Brandli P., Loffler B.-M., Breu V., Osterwalder R., Maire J.-P., Clozel M. Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater. Pain. 64:1996;315-322.
2. Burgos C., Aguirre J.A., Alonso J.R., Coveñas R. Immunocytochemical study of substance P-like fibers and cell bodies in the rat diencephalon. J Hirnforsch. 29:1988;651-657.
3. Buzzi M.G., Carter W.B., Shimizu T., Heath H. III, Moskowitz M.A. Dihydroergotamine and Sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology. 30:1991;1193-1200.
4. Davis K.D., Dostrovsky J. Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulation. Pain. 25:1986;395-401.
5. Diener H.C. Substance-P antagonist RPR100893-201 is not effective in human migraine attacks. Olesen J., Tfelt-Hansen P. Proceedings of the VIth international headache seminar. 1996;Lippincott-Raven, New York.
6. Edvinsson L., Brodin E., Jansen I., Uddman R. Neurokinin A in cerebral vessels: characterization, localization and effects in vitro. Regul Pept. 20:1988;181-197.
7. Friberg L., Olesen J., Olsen T.S., Karle A., Ekman R., Fahrenkrug J. Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura. Cephalalgia. 14:1994;47-54.
8. Gallai V., Sarchielli P., Floridi A., Francceschini M., Codini M., Trequattrini A., Palumbo R. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia. 15:(384):1995;390.
9. Gamse R., Saria A. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide. Eur J Pharmacol. 114:1985;61-66.
10. Gamse R., Saria A. Nociceptive behavior after intrathecal injection of substance P, neurokinin A and calcitonin gene-related peptide in mice. Neurosci Lett. 70:1986;143-147.
11. Goadsby P.J., Edvinsson L., Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol. 23:1988;193-196.
12. Goadsby P.J., Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of human during migraine headache. Ann Neurol. 28:1990;183-187.
13. Goadsby P.J., Hoskin K.L., Knight Y.E. Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation. Neuroscience. 86:1998;337-343.
14. Goldstein D.J., Wang O., Saper J.R., Stoltz R., Silberstein S.D., Mathew N.T. Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Cephalalgia. 17:1997;785-790.
15. Goodman E.C., Iversen L.L. Calcitonin gene-related peptide: Novel neuropeptide. Life Sci. 38:1986;2169-2178.
16. Greves L.E., Nyberg F., Terenius L., Hökfelt T. Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur J Pharmacol. 115:1985;309-311.
17. Hökfelt T., Keller J.O., Nilson G., Pernow B. Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res. 19:1975;235-252.
18. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 24:1988;739-768.
19. Hoskin K.L., Kaube H., Goadsby P.J. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain. 119:1996;1419-1428.
20. Hua X.Y., Saria A., Gamse R., Theodorsson-Norheim E., Brodin E., Lundberg J.M. Capsaicin-induced release of multiple tachykinins (substance P and eledosin-like material) from guinea-pig spinal cord and ureter. Neuroscience. 19:1986;313-319.
21. Kaube H., Keay K.A., Hoskin K.L., Bandler R., Goadsby P.J. Expression of c-fos like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in cat. Brain Res. 629:1993;95-102.
22. Knyihár Csillik E., Tajti J., Samsam M., Sáry G., Slezak S., Vécsei L. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of the c-fos in the caudal trigeminal nucleus in an experimental migraine model. J Neurosci Res. 48:1997;449-464.
23. Knyihár Csillik E., Tajti J., Samsam M., Sáry G., Buzás P., Vécsei L. Depletion of calcitonin gene-related peptide from the caudal trigeminal nucleus of the rat after electrical stimulation of the Gasserian ganglion. Exp Brain Res. 118:1998;111-114.
24. Lembeck F., Gamse R. Lack of algesia effect of substance P on paravascular pain receptors. Naunyn Schmiedebergs Arch Pharmacol. 299:1977;295-303.
25. Marcos P., Coveñas R., de León M., Narváez J.A., Tramu G., Aguirre J.A., González-Barón S. Neurokinin A-like immunoreactivity in the cat brain-stem. Neuropeptides. 25:1993;105-114.
26. Marcos P., Coveñas R., Narváez J.A., Aguirre J.A., Tramu G., González-Barón S. Mapping of enkephalins-, neuropeptide Y-, calcitonin gene-related peptide-, and gastrin-releasing peptide/bombesin-like immunoreactivities in the cat amygdala. Peptides. 20:1999;635-644.
27. Markowitz S., Saito K., Moskowitz M.A. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci. 7:1987;4129-4136.
28. May A., Gijsman H.J., Wallnoefer A., Jones R., Diener H.C., Ferrari M.D. Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks. Pain. 67:1996;375-378.
29. Moskowitz M.A. The neurobiology of vascular head pain. Ann Neurol. 16:1984;157-168.
30. Moskowitz M.A., Buzzi M.G., Sakas D.E., Linnik M.D. Pain mechanisms underlying vascular headaches. Rev Neurol. 145:1989;181-193.
31. Nikolodi M. Del Bianco. E. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache. Cephalalgia. 10:1990;39-50.
32. Nozaki K., Boccalin P., Moskowitz M.A. Expression of c-fos-like immunoreactivity in brain-stem after meningeal irritation by blood in the subarachnoid space. Neuroscience. 49:1992;669-680.
33. O'Connor T.P., Van der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene-related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci. 8:1988;2468-2476.
34. Oku R., Satoh M., Fujii N., Otaka A., Yajima H., Takagi H. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res. 403:1987;350-354.
35. Otsuka M., Konishi S. Release of substance P-like immunoreactivity from isolated spinal cord of new born rat. Nature. 264:1976;83-84.
36. Otsuka M., Konishi S., Yanagisawa M., Tsunoo A., Akagi H. Role of substance P as a sensory transmitter in spinal cord and sympathetic ganglia. Ciba Found Symp. 91:1982;13-34.
37. Pedersen-Bjergaard U., Nielsen L.B., Jensen K., Edvinsson L., Jansen I., Olesen J. Calcitonin gene-related peptide, neurokinin A and substance P: effects on nociception and neurogenic inflammation in human skin and temporal muscle. Peptides. 12:1991;333-337.
38. Penfield W., McNaughton F. Dural headaches and the innervation of the dura mater. Am Neurol Assoc. 64:1983;106-109.
39. Polley J.S., Gaskin P.J., Perren M.J., Connor H.E., Ward P., Beattie D.T. The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system. Regul Pept. 68:1997;23-29.
40. Saria A., Ma R.C., Dun N.J. Neurokinin A depolarizes neurons of the guinea pig inferior mesenteric ganglia. Neurosci Lett. 60:1985;145-150.
41. Saria A., Gamse R., Petermen J., Fischer J., Theodersson-Norheim E., Lundberg J.M. Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices. Neurosci Lett. 63:1986;310-314.
42. Saxena P.R. Progress in 5-HT receptor classification. Newslett Eur Headache Fed. 3:1994;1-8.
43. Schneider J.S., Denaro F.J., Olazabal U.E., Leard H.O. Stereotaxic atlas of the trigeminal ganglion in rat, cat, and monkey. Brain Res Bull. 7:1981;93-95.
44. Shepheard S.L., Williamson D.J., Hill R.G., Hargreaves R.J. The non-peptide neurokinin1 receptor antagonist RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br J Pharmacol. 108:1993;11-12.
45. Uddman R., Edvinsson L., Ekman R., Kingman T., McCulloch J. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett. 62:1985;131-136.
46. Vécsei L., Tajti J. Knyihár Csillik. E., Samsam, M. Neuropeptides and migraine: the role of CGRP. Cephalalgia. 16:1995;3.
47. Wiesenfeld-Halin Z., Hökfelt T., Lundberg J.M., Forssmann W.G., Reinecke M., Tschopp F.A., Fischer J.A. Immunoreactive calcitonin gene-related peptide and substance P co-exist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat. Neurosci Lett. 52:1984;199-204.
48. Woolf C., Wiesenfeld-Hallin Z. Substance P and calcitonin gene-related peptide synergistically modulate the gain of the nociceptive flexor withdrawal reflex in the rat. Neurosci Lett. 66:1986;226-230.